Found: 24
Select item for more details and to access through your institution.
IL-18 But Not IL-1 Signaling Is Pivotal for the Initiation of Liver Injury in Murine Non-Alcoholic Fatty Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8602, doi. 10.3390/ijms21228602
- By:
- Publication type:
- Article
Protective and Aggravating Effects of Nlrp3 Inflammasome Activation in IBD Models: Influence of Genetic and Environmental Factors.
- Published in:
- Digestive Diseases, 2012, v. 30, p. 82, doi. 10.1159/000341681
- By:
- Publication type:
- Article
Ischemic Postconditioning (IPostC) Protects Fibrotic and Cirrhotic Rat Livers after Warm Ischemia.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2019, p. 1, doi. 10.1155/2019/5683479
- By:
- Publication type:
- Article
Volcanic Ash Activates the NLRP3 Inflammasome in Murine and Human Macrophages.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2017.02000
- By:
- Publication type:
- Article
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 10, p. 2101, doi. 10.1007/s00262-020-02605-9
- By:
- Publication type:
- Article
Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8 T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 4, p. 321, doi. 10.1007/s00262-013-1510-y
- By:
- Publication type:
- Article
Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 6, p. 901, doi. 10.1007/s00262-008-0606-2
- By:
- Publication type:
- Article
IFN Regulatory Factor 4 Controls Post-ischemic Inflammation and Prevents Chronic Kidney Disease.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02162
- By:
- Publication type:
- Article
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.
- Published in:
- Nature, 2010, v. 464, n. 7293, p. 1357, doi. 10.1038/nature08938
- By:
- Publication type:
- Article
OAS1/RNase L executes RIG-I ligand–dependent tumor cell apoptosis.
- Published in:
- Science Immunology, 2021, v. 6, n. 61, p. 1, doi. 10.1126/sciimmunol.abe2550
- By:
- Publication type:
- Article
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent Manner.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.595390
- By:
- Publication type:
- Article
Immunotherapy in Tumors.
- Published in:
- Deutsches Ärzteblatt International, 2015, v. 112, n. 48, p. 809, doi. 10.3238/arztebl.2015.0809
- By:
- Publication type:
- Article
Interferon-α disables dendritic cell precursors: dendritic cells derived from interferon-α-treated monocytes are defective in maturation and T-cell stimulation.
- Published in:
- Immunology, 2003, v. 110, n. 1, p. 38, doi. 10.1046/j.1365-2567.2003.01702.x
- By:
- Publication type:
- Article
To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning.
- Published in:
- Digestive Diseases & Sciences, 2021, v. 66, n. 4, p. 1349, doi. 10.1007/s10620-020-06328-w
- By:
- Publication type:
- Article
Multifunctional antitumor molecule 5′-triphosphate siRNA combining glutaminase silencing and RIG-I activation.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 8, p. 1958, doi. 10.1002/ijc.28416
- By:
- Publication type:
- Article
CD103 is a hallmark of tumor-infiltrating regulatory T cells.
- Published in:
- International Journal of Cancer, 2011, v. 129, n. 10, p. 2417, doi. 10.1002/ijc.25902
- By:
- Publication type:
- Article
An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 4, p. 897, doi. 10.1002/ijc.25399
- By:
- Publication type:
- Article
Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant.
- Published in:
- Immunology & Cell Biology, 2009, v. 87, n. 5, p. 371, doi. 10.1038/icb.2009.21
- By:
- Publication type:
- Article
Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv146
- By:
- Publication type:
- Article
Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of a New Fusion Receptor on PD-1--Mediated Immunosuppression in Adoptive T Cell Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv146
- By:
- Publication type:
- Article
Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Selective Bispecific T Cell Recruiting Antibody and Antitumor Activity of Adoptive T Cell Transfer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 107, n. 1, p. 1, doi. 10.1093/jnci/dju364
- By:
- Publication type:
- Article